Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?

Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?

Pancreatic ductal adenocarcinoma cancer (PDAC) is a highly diverse disease with low tumor immunogenicity. PDAC is also one of the deadliest solid tumor and will remain a common cause of cancer death in the future. Treatment options are limited, and tumors frequently develop resistance to current tre...

Full description

Bibliographic Details
Main Authors: Sofian Benkhaled, Cedric Peters, Nicolas Jullian, Tatjana Arsenijevic, Julie Navez, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
pancreatic cancer
radiotherapy
immunotherapy
immune checkpoint inhibition
tumor microenvironment
targeted therapy
Online Access:https://www.mdpi.com/2072-6694/15/3/768

Internet

https://www.mdpi.com/2072-6694/15/3/768

Similar Items